AsthmALLERGICa &RHINITIS COPD MTREATMENTSedications ICS, inhaled | inhaled corticosteroid ICS, SABA Relievers CORTICOSTEROID ICS Preventers ANTIHISTAMINE ICS/LABAANTIHISTAMINE/ COMBINATION S SALINE LAMA CORTICOSTEROID LABA, long-acting beta long-acting LABA, a Flixotide Inhaler † Cipla Inhaler † Seretide MDI Fluticasone + Spiriva Respimat # ‡/a Spiriva Handihaler # Ventolin Inhaler † ^ Asmol Inhaler † ^ a 100mcg salbutamol 100mcg fluticasone propionate fluticasone propionate/salmeterol Cipla Inhaler tiotropium 2.5mcg tiotropium 18mcg 50mcg* • 125mcg • 250mcg 125mcg • 250mcg 50/25 • 125/25 • 250/25 c fluticasone propionate/salmeterol *Flixotide Junior 125/25 • 250/25 c

Flixonase Avamys* Omnaris* Azep Dymista*

Fess Saline Spray (nasal spray) 2 fluticasone propionate azelastine azelastine/fluticasone propionate | agonist Sodium chloride 50mcg 27.5mcg 50mcg 125mcg 125mcg/50mcg 9mg/mL LAMA, long-acting | antagonist muscarinic long-acting LAMA, Bricanyl Turbuhaler a c Airomir Autohaler ‡ # a a 500mcg salbutamol 100mcg Flixotide Accuhaler † QVAR Inhaler † Seretide Accuhaler Flutiform Inhaler Braltus Zonda # Bretaris Genuair # fluticasone propionate fluticasone propionate/salmeterol fluticasone propionate/ tiotropium 13mcg aclidinium 322mcg 100mcg* • 250mcg • 500mcg 50mcg • 100mcg 100/50 • 250/50 • 500/50 c 50/5 • 125/5 • 250/10 Resources sAMA

TREATMENT GUIDELINES Australian Handbook: asthmahandbook.org.au a a

Atrovent Metered Aerosol † beta short-acting SABA, COPD-X Plan: ^ Pulmicort Turbuhaler † QVAR Autohaler ‡ Symbicort Turbuhaler DuoResp Spiromax Seebri Breezhaler # Incruse Ellipta # ipratropium 21mcg budesonide/formoterol Beconase Rhinocort Hayfever • Rhinocort* Nasonex Allergy • Nasonex*beclometasone Zyrtec budesonide/formoterol Atrovent Nasal • Fess Sinu Cleanseglycopyrronium (nasal irrigation) 50mcg umeclidinium 62.5mcg copdx.org.au 100mcg • 200mcg • 400mcg c 200/6 • 400/12 c beclometasone budesonide† † 50mcg • 100mcg levocabastine 100/6 • 200/6 • 400/12 Atrovent Nasal Forte Sodium chloride

50mcg 32mcg • 64mcg 50mcg 0.5mg/mL ipratropium 9mg/mL 22mcg • 44mcg multiple brands available †generic brandsNo also availablen ste roidal LAmA/LAbA COMBINATIONS Inhaler Preventer Technique How-to videos, patient and DECONGESTANT 2 practitioner information | agonist nationalasthma.org.au SAMA, short-acting muscarinic antagonist muscarinic short-acting SAMA, Inhalers/MDIs should Tablet a a c Alvesco Inhaler † Arnuity Ellipta † Symbicort Rapihaler Breo Ellipta a Spiolto Respimat c Brimica Genuair be used with a montelukast ciclesonide fluticasone furoate budesonide/formoterol fluticasone furoate/vilanterol tiotropium/ aclidinium/formoterol 4mg • 5mg • 10mg compatible spacer 80mcg • 160mcg 50mcg • 100mcg • 200mcg 50/3 • 100/3 • 200/6 c 100/25 c • 200/25 2.5/2.5 340/12 Generic medicine suppliers

How-to videos Laba medications ICS/LAMA/LABA MediFess Value Pack ‡ Livostin Decongestant Decongestant Spray Tish Otrivin Plus /ipratropium sodium chloride mometasone† levocabastine xylometazoline tramazoline 0.5mg/mL/0.6mg/mL 9mg/mL 50mcg 0.5mg/mL multiple brands available 82mcg ‡ available only as value pack short-term use only

*Available by prescription only. PBS subsidisation is not available on most nasal sprays. RPBS subsidisation is available for selected nasal sprays - check current criteria.

c c c Oxis Turbuhaler ‡ Serevent Accuhaler ‡ Onbrez Breezhaler # Fostair Inhaler a Ultibro Breezhaler Anoro Ellipta Trelegy Ellipta formoterol salmeterol beclometasone/formoterol indacaterol/glycopyrronium umeclidinium/vilanterol fluticasone furoate/ 6mcg • 12mcg 50mcg 150mcg • 300mcg 100/6 110/50 62.5/25 umeclidinium/vilanterol all units in mcg all units in mcg 100/62.5/25mcg

This chart was developed independently by the National Asthma Council Australia with support from PBR S P ESCRIBERS † Asthma unrestricted benefit ‡ Asthma restricted benefit a Asthma authority required ^ COPD unrestricted benefit # COPD restricted benefit C COPD authority required Mylan Health, Chiesi Australia, GSK Australia & AstraZeneca Australia Check TGA and PBS for current age and condition criteria 2020 © National Asthma Council Australia